Transboundary and Emerging Diseases

About this Journal

Aims and scope

Transboundary and Emerging Diseases brings together original research and review articles on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks.

Submissions should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to research focusing on novel science-based approaches to controlling transboundary and emerging diseases.

The following topics are generally considered out of scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):

  1. Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
  2. Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique.
  3. Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
  4. Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
  5. Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.

    The Wiley Hindawi Partnership

    This journal is published by Hindawi as part of a publishing collaboration with John Wiley & Sons, Inc. It is a fully open access journal produced under the Hindawi and Wiley brands. 

    Bibliographic information

    ISSN: 1865-1674 (Print) 

    ISSN: 1865-1682 (Online) 

    DOI: 10.1155/tbed

      Archival content

      Content published prior to 2023 is hosted on the Wiley Online Library.

        Open Access

        Transboundary and Emerging Diseases is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our copyright page.

          Contact

          Editorial enquiries should be directed to tbed@hindawi.com.

          General enquiries should be directed to help@hindawi.com.

           

            Transboundary and Emerging Diseases
            Publishing Collaboration
            More info
            Wiley Hindawi logo
             Journal metrics
            See full report
            Acceptance rate34%
            Submission to final decision111 days
            Acceptance to publication24 days
            CiteScore7.400
            Journal Citation Indicator1.450
            Impact Factor4.3
             Submit Evaluate your manuscript with the free Manuscript Language Checker

            We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.